Related Experiment Videos
Perinatal stroke--risk factors and management
1Department of Haematology, Royal Hospital for Sick Children, Yorkhill, Glasgow, UK. elizabeth.chalmers@yorkhill.scot.nhs.uk
British Journal of Haematology
|July 27, 2005
Summary
Pediatric stroke, often thromboembolic, is a serious cause of childhood mortality and neurological issues, particularly in newborns. Understanding its complex, multifactorial causes requires interdisciplinary collaboration for better prevention and treatment.
Area of Science:
- Pediatric Neurology
- Neonatology
- Hematology
Background:
- Stroke is an uncommon but significant cause of mortality and long-term neurological morbidity in children.
- Cerebral thromboembolic events are a major contributor, with incidence peaking in the neonatal period.
- Perinatal strokes may have distinct risk factors compared to those in older children, potentially occurring in utero or perinatally.
Purpose of the Study:
- To explore the complex pathophysiology of perinatal stroke.
- To identify multifactorial risk factors, including maternal, placental, fetal, and neonatal disorders.
- To highlight the need for interdisciplinary collaboration and investigate the role of prothrombotic abnormalities and antithrombotic agents.
Main Methods:
- Review of existing literature on childhood stroke and thromboembolic disease.
- Analysis of potential risk factors in maternal, placental, fetal, and neonatal populations.
- Discussion of the implications for hematology, focusing on prothrombotic states and antithrombotic therapies.
Main Results:
- Perinatal stroke pathophysiology is complex and often multifactorial.
- Risk factors encompass maternal, placental, fetal, and neonatal conditions.
- Prospective studies are needed to delineate the contribution of each factor.
Conclusions:
- Perinatal stroke is a complex condition requiring a multidisciplinary approach involving obstetrics, fetal medicine, pathology, neonatology, and neurology.
- Further research is essential to understand the contribution of prothrombotic abnormalities and evaluate antithrombotic strategies for management and prevention.